Zogenix Company Profile (NASDAQ:ZGNX)

About Zogenix

Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders in requirement of treatment alternatives. The Company's areas of focus are epilepsy and schizophrenia. Its lead product candidate, ZX008, is a low-dose fenfluramine. The Company is also engaged in the development of Relday, which is a long-acting injectable formulation of risperidone indicated for the treatment of symptoms of schizophrenia and bipolar disorder in adults and teenagers 13 years of age and older. The Company is also engaged in manufacturing Sumavel DosePro (sumatriptan injection), a needle-free delivery system, which it sells to Endo Ventures Bermuda Limited and Endo Ventures Limited. Its DosePro technology is a drug delivery system designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drug Manufacturers - Major
Sub-Industry: Pharmaceuticals
Exchange: NASDAQ
Symbol: ZGNX
CUSIP: 98978L10

Key Metrics:

Previous Close: $9.52
50 Day Moving Average: $9.31
200 Day Moving Average: $9.43
52-Week Range: $24,790,000.00 - $7.33
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -3.38
P/E Growth: -0.12
Market Cap: $259.06M
Outstanding Shares: 24,790,000
Beta: 1.76

Profitability:

Net Margins: -192.64%
Return on Equity: -33.62%
Return on Assets: -19.94%

Debt:

Debt-to-Equity Ratio: 0.14%
Current Ratio: 10.58%
Quick Ratio: 9.74%

Additional Links:

Companies Related to Zogenix:

Consensus Ratings for Zogenix (NASDAQ:ZGNX) (?)

Ratings Breakdown:	1 Hold Rating, 3 Buy Ratings
Consensus Rating:	Buy (Score: 2.75)
Consensus Price Target:	$25.67 (145.61% upside)

Analysts' Ratings History for Zogenix (NASDAQ:ZGNX)

Show:

Date	Firm	Action	Rating	Price Target
9/21/2016	Brean Capital	Reiterated Rating	Buy	$28.00
11/27/2015	Leerink Swann	Reiterated Rating	Outperform	$26.00
11/10/2015	William Blair	Initiated Coverage	Hold
10/21/2015	Oppenheimer Holdings Inc.	Reiterated Rating	Buy	$23.00
4/21/2015	Piper Jaffray Cos.	Initiated Coverage	Overweight	$2.50

(Data available from 9/25/2014 forward)

Earnings History for Zogenix (NASDAQ:ZGNX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/7/2016
8/9/2016	Q216	($0.81)	($0.76)	$5.36 million	$2.10 million	View	N/A
5/10/2016	Q116	($0.62)	($0.42)	$4.90 million	$9.20 million	View	Listen
3/10/2016	Q415	($0.69)	($0.36)	$6.39 million	$6.10 million	View	Listen
11/9/2015	Q315	($0.74)	($0.65)	$5.90 million	$9.12 million	View	N/A
8/10/2015	Q215	($0.77)	$3.78	$5.13 million	$7.40 million	View	Listen
5/11/2015	Q115	($0.13)	($0.15)	$8.54 million	$4.60 million	View	Listen
3/10/2015	Q414	($0.11)	($0.13)		$14.90 million	View	Listen
11/6/2014	Q314	($0.16)	($0.15)	$8.30 million	$8.80 million	View	Listen
8/5/2014	Q214	($0.16)	($0.19)	$9.84 million	$9.16 million	View	Listen
5/8/2014	Q114	($0.17)	($0.20)	$8.71 million	$7.70 million	View	Listen
3/5/2014	Q413	($0.09)	($0.13)	$8.68 million	$9.90 million	View	Listen
11/4/2013	Q313	($0.09)	($0.12)	$9.33 million	$7.20 million	View	N/A
8/8/2013	Q2 2013	($0.15)	($0.13)	$8.63 million	$8.90 million	View	Listen
5/9/2013	Q1 2013	($0.14)	($0.21)	$9.28 million	$7.00 million	View	Listen
3/15/2013	Q4 2012	($0.17)	($0.16)	$9.87 million	$9.50 million	View	Listen
11/8/2012	Q312	($0.16)	($0.16)	$9.98 million	$8.50 million	View	N/A
8/8/2012		($0.28)	($0.26)			View	N/A
5/14/2012		($0.14)	($0.16)			View	N/A
3/8/2012		($0.36)	($0.36)			View	N/A
11/10/2011		($0.55)	($0.59)			View	N/A
5/16/2011		($0.50)	($0.56)			View	N/A
3/3/2011		($0.62)	($0.04)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Zogenix (NASDAQ:ZGNX)

Current Year EPS Consensus Estimate: $-3.24 EPS
Next Year EPS Consensus Estimate: $-3.09 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.72)	($0.72)	($0.72)
Q2 2016	2	($0.88)	($0.81)	($0.85)
Q3 2016	3	($1.00)	($0.83)	($0.91)
Q4 2016	3	($1.13)	($0.95)	($1.06)

(Data provided by Zacks Investment Research)

Dividend History for Zogenix (NASDAQ:ZGNX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Zogenix (NASDAQ:ZGNX)

Insider Ownership Percentage: 5.00%
Institutional Ownership Percentage: 84.91%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/15/2015	Roger Hawley	Director	Buy	10,000	$13.74	$137,400.00
6/13/2014	Cam L Garner	Director	Buy	30,000	$1.66	$49,800.00
6/3/2014	Ann D Rhoads	CFO	Sell	19,229	$2.10	$40,380.90
6/3/2014	Roger Hawley	CEO	Sell	25,078	$2.10	$52,663.80
6/3/2014	Stephen J Farr	COO	Sell	20,900	$2.10	$43,890.00
11/20/2013	Richard Scott Shively	Insider	Buy	67,000	$2.79	$186,930.00
12/13/2012	Cynthia Y Robinson	Insider	Buy	50,000	$1.17	$58,500.00
12/12/2012	Ann D Rhoads	CFO	Buy	17,500	$1.19	$20,825.00
12/12/2012	Cam L Garner	Director	Buy	70,000	$1.21	$84,700.00
12/11/2012	Erle T Mast	Director	Buy	10,000	$1.15	$11,500.00

(Data available from 1/1/2013 forward)

Latest Headlines for Zogenix (NASDAQ:ZGNX)

Date	Headline
	Zogenix Inc. (NASDAQ: ZGNX) Rating Reiterated at Brean Capital - BNB Daily (blog) (NASDAQ:ZGNX) www.baseball-news-blog.com - September 23 at 5:01 AM
	Zogenix to Participate in Two Upcoming Investor Conferences - Yahoo Finance (NASDAQ:ZGNX) finance.yahoo.com - September 20 at 8:33 AM
	Zogenix to Participate in Two Upcoming Investor Conferences (NASDAQ:ZGNX) www.publicnow.com - September 20 at 8:33 AM
	Analyst Watch-list: Matrix Service Company (NASDAQ:MTRX) , Zogenix, Inc. (NASDAQ:ZGNX) , - Wall Street Times (press release) (NASDAQ:ZGNX) www.wallstreetnews24.com - September 16 at 7:54 PM
	Zogenix Inc. (ZGNX) Stock Price Down 2.5% - NewsDen (NASDAQ:ZGNX) newsden.net - September 15 at 12:02 PM
	ETF’s with exposure to Zogenix, Inc. : September 15, 2016 (NASDAQ:ZGNX) www.capitalcube.com - September 15 at 12:02 PM
	Investor Scope: Checking in on Shares of Zogenix, Inc. (NASDAQ:ZGNX) - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 14 at 12:39 PM
	Trading Watch: Session Activity Review on Shares of Zogenix, Inc. (NASDAQ:ZGNX) Shares - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 14 at 12:39 PM
	Stocks within Analyst Limelight: Sorrento Therapeutics, Inc. (NASDAQ:SRNE) , Zogenix, Inc. (NASDAQ:ZGNX) - Wall Street Times (press release) (NASDAQ:ZGNX) www.wallstreetnews24.com - September 13 at 5:26 AM
	Market Focus: Checking on Session Activity for Zogenix, Inc. (NASDAQ:ZGNX) Shares - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 13 at 5:26 AM
	Market Review: Watching Session Activity of Zogenix, Inc. (NASDAQ:ZGNX) Shares - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 10 at 5:25 AM
	Stock Tracker: Earnings & Estimates for Zogenix, Inc. (NASDAQ:ZGNX) - Frisco Fastball (NASDAQ:ZGNX) friscofastball.com - September 10 at 5:25 AM
	Stock Update (NASDAQ:ZGNX): Zogenix, Inc. to have Significant ... - Smarter Analyst (NASDAQ:ZGNX) www.smarteranalyst.com - September 9 at 5:25 AM
	Zogenix to have Significant Presence at 12th European Congress on Epileptology (NASDAQ:ZGNX) www.publicnow.com - September 8 at 7:51 PM
	Placing Zogenix, Inc. (NASDAQ:ZGNX) Shares Under the Microscope - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 8 at 12:10 PM
	Trading Update: Following Activity of Zogenix, Inc. (NASDAQ:ZGNX) Shares During the Current Session - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 7 at 12:09 PM
	Stock Struggling for the Quarter: Zogenix, Inc. (NASDAQ:ZGNX) - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 4 at 5:13 AM
	Analyst Watch-list: China Commercial Credit, Inc. (NASDAQ:CCCR) , Zogenix, Inc. (NASDAQ:ZGNX) - Wall Street Times (press release) (NASDAQ:ZGNX) www.wallstreetnews24.com - September 2 at 8:02 PM
	Investor Beat: Watching Activity of Zogenix, Inc. (NASDAQ:ZGNX) Shares During the Session - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 2 at 8:02 PM
	Stock in Review: Taking a Closer Look at Zogenix, Inc. (NASDAQ:ZGNX) Shares - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - September 2 at 6:14 AM
	Investors are Sharpening Their Focus on Shares of Zogenix, Inc. (NASDAQ:ZGNX) - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - August 31 at 5:17 AM
	ZOGENIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:ZGNX) biz.yahoo.com - August 26 at 7:58 PM
	Crowd is Weighing in on Zogenix, Inc. (NASDAQ:ZGNX) - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - August 21 at 5:01 AM
	Earnings At Glance for Zogenix, Inc. (NASDAQ:ZGNX) - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - August 19 at 8:13 PM
	ZOGENIX, INC. Financials (NASDAQ:ZGNX) finance.yahoo.com - August 19 at 8:13 PM
	Retail & Analyst Ratings Forecasts on Zogenix, Inc. (NASDAQ:ZGNX ... - Post News (NASDAQ:ZGNX) www.kentuckypostnews.com - August 18 at 8:37 PM
	ETF’s with exposure to Zogenix, Inc. : August 15, 2016 (NASDAQ:ZGNX) www.capitalcube.com - August 15 at 8:44 PM
	Zogenix, Inc. :ZGNX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:ZGNX) www.capitalcube.com - August 12 at 8:34 PM
	Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results (NASDAQ:ZGNX) globenewswire.com - August 9 at 8:45 PM
	Zogenix Inc.: Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results (NASDAQ:ZGNX) www.twst.com - August 9 at 8:45 PM
	Zogenix reports 2Q loss (NASDAQ:ZGNX) sg.finance.yahoo.com - August 9 at 8:45 PM
	Q2 2016 Zogenix Inc Earnings Release - After Market Close (NASDAQ:ZGNX) biz.yahoo.com - August 9 at 11:56 AM
	Zogenix Inc.: Zogenix to Release Second Quarter 2016 Financial Results and Host Conference Call and Webcast on August 9 (NASDAQ:ZGNX) www.twst.com - August 2 at 8:50 PM
	Zogenix to Release Second Quarter 2016 Financial Results and Host Conference Call and Webcast on August 9 (NASDAQ:ZGNX) www.publicnow.com - August 2 at 8:50 PM
	Zogenix, Inc. (ZGNX) Updated Price Targets - FTSE News.co.uk - FTSE News (NASDAQ:ZGNX) www.ftsenews.co.uk - July 29 at 11:31 AM
	Zogenix Inc. (ZGNX) is Trading Higher on Unusual Volume for July 25 - Equities.com (NASDAQ:ZGNX) www.equities.com - July 27 at 11:40 AM
	Trading Examination: Performance check on Zogenix, Inc. (NASDAQ:ZGNX) - TGP (NASDAQ:ZGNX) telanaganapress.com - July 22 at 11:22 AM
	Earnings Focus and Crowd Sourced Sentiment Review for Zogenix, Inc. (NASDAQ:ZGNX) - TGP (NASDAQ:ZGNX) telanaganapress.com - July 21 at 11:16 AM
	Trading Recap: Moving Stock Watch Zogenix, Inc. (NASDAQ:ZGNX) - Press Telegraph (NASDAQ:ZGNX) presstelegraph.com - July 20 at 9:34 PM
	Will Zogenix, Inc. (NASDAQ:ZGNX) Surprise This Quarter? - Investor Newswire (NASDAQ:ZGNX) www.investornewswire.com - July 20 at 9:34 PM
	EPS Growth in Focus for Zogenix, Inc. (NASDAQ:ZGNX) - TGP (NASDAQ:ZGNX) telanaganapress.com - July 20 at 9:34 PM
	Trading Performance and Target Watch for Zogenix, Inc. (NASDAQ:ZGNX) - Press Telegraph (NASDAQ:ZGNX) presstelegraph.com - July 19 at 8:38 PM
	Zogenix, Inc. (NASDAQ:ZGNX): Stock Insight and Session Performance Spotcheck - Press Telegraph (NASDAQ:ZGNX) presstelegraph.com - July 19 at 8:38 PM
	Investors are Intently Watching Shares of: Zogenix, Inc. (NASDAQ:ZGNX) - Press Telegraph (NASDAQ:ZGNX) presstelegraph.com - July 19 at 8:38 PM
	Consensus Analyst Target Price Check for Zogenix, Inc. (NASDAQ:ZGNX) - Press Telegraph (NASDAQ:ZGNX) presstelegraph.com - July 19 at 8:38 PM
	Analysts Bullish on Stock: Zogenix, Inc. (NASDAQ:ZGNX) - TGP (NASDAQ:ZGNX) telanaganapress.com - July 19 at 8:38 PM
	Company Shares in Focus: Zogenix, Inc. (NASDAQ:ZGNX) - Press Telegraph (NASDAQ:ZGNX) presstelegraph.com - July 17 at 7:48 PM
	Zogenix, Inc. (NASDAQ:ZGNX) Check on Sentiment Score - Press Telegraph (NASDAQ:ZGNX) presstelegraph.com - July 17 at 7:48 PM
	EPS Growth Watch for Zogenix, Inc. (NASDAQ:ZGNX) - TGP (NASDAQ:ZGNX) telanaganapress.com - July 17 at 7:48 PM
	Earnings Surprise in Focus: Zogenix, Inc. (NASDAQ:ZGNX) - Investor Newswire (NASDAQ:ZGNX) www.investornewswire.com - July 17 at 7:48 PM